Pneumonia Vaccine Market by Vaccine Type, by Product Type and By Sector, by Distribution Channel: Opportunity Analysis and Industry Forecast, 2023-2033

The global Pneumonia Vaccine market was valued at USD 10.23 billion in 2022 and expected to grow at a CAGR of 6.7% during the forecast period.

Pneumonia vaccines are vaccines designed to prevent or reduce the severity of pneumococcal disease, which is caused by the bacterium Streptococcus pneumonia. Pneumonia can cause a range of symptoms, including fever, cough, chest pain, difficulty breathing, and fatigue, and can lead to serious complications such as sepsis and meningitis. Pneumonia vaccines are recommended for people who are at increased risk of developing pneumococcal disease, including: Infants and young children, Adults over 65 years of age, Individuals with weakened immune systems.

Get the report with Full Information: - https://wemarketresearch.com/r....eports/pneumonia-vac